Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.38 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 12/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 12/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 11/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | PRKDC | P78527 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16067815 | 0.98 | CYP1A1 (0.39) | PLA2G2APLA2G4APLA2G10CYP1A1CYP1B1 | |
| SCHEMBL22868287 | 0.96 | CYP1A1 (0.39) | PLA2G2APLA2G4APLA2G10CYP1A1CYP1B1 | |
| SCHEMBL27335478 | 0.94 | ALOX5 (0.40) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT | |
| SCHEMBL19081530 | 0.94 | ALOX5 (0.38) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT | |
| SCHEMBL16068020 | 0.94 | ALOX5 (0.41) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT | |
| SCHEMBL19081545 | 0.93 | CYP1A1 (0.36) | PLA2G2APLA2G4APLA2G10CYP1A1CYP1B1 | |
| SCHEMBL17945168 | 0.93 | CYP1A1 (0.43) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT | |
| SCHEMBL10122426 | 0.93 | ALOX5 (0.44) | PLA2G2APLA2G4APLA2G10CYP1A2ALDH1A1 | |
| SCHEMBL16067569 | 0.91 | ALOX5 (0.39) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT | |
| SCHEMBL16067849 | 0.91 | ALOX5 (0.42) | CYP1A1CYP1B1CYP1A2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10553800-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNT1 | PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885 |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.